Kristofer J. Thurecht

10.8k total citations · 2 hit papers
212 papers, 8.7k citations indexed

About

Kristofer J. Thurecht is a scholar working on Biomaterials, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Kristofer J. Thurecht has authored 212 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Biomaterials, 68 papers in Molecular Biology and 57 papers in Organic Chemistry. Recurrent topics in Kristofer J. Thurecht's work include Nanoparticle-Based Drug Delivery (59 papers), RNA Interference and Gene Delivery (44 papers) and Advanced Polymer Synthesis and Characterization (42 papers). Kristofer J. Thurecht is often cited by papers focused on Nanoparticle-Based Drug Delivery (59 papers), RNA Interference and Gene Delivery (44 papers) and Advanced Polymer Synthesis and Characterization (42 papers). Kristofer J. Thurecht collaborates with scholars based in Australia, United Kingdom and Singapore. Kristofer J. Thurecht's co-authors include Simon R. Corrie, Kye J. Robinson, Jiaul Islam, Andrew K. Whittaker, Steven M. Howdle, Idriss Blakey, Nicholas L. Fletcher, Zachary H. Houston, Frank Caruso and Hui Peng and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Kristofer J. Thurecht

206 papers receiving 8.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

2016 1.9k citations Kristofer J. Thurecht et al. profile →
Minimum information reporting in bio–nano experimental literature

2018 482 citations Matthew Faria, Mattias Björnmalm et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristofer J. Thurecht Australia	44	3.4k	3.0k	2.5k	1.9k	1.7k	212	8.7k
Cameron Alexander United Kingdom	51	3.3k 1.0×	3.5k 1.1×	2.9k 1.2×	1.7k 0.9×	3.1k 1.8×	301	11.7k
Nicola Tirelli United Kingdom	50	3.1k 0.9×	2.6k 0.8×	2.0k 0.8×	1.5k 0.8×	2.3k 1.3×	197	8.8k
Qiao Jin China	56	3.5k 1.0×	5.5k 1.8×	2.8k 1.1×	3.2k 1.7×	2.3k 1.3×	259	11.2k
Simona Mura France	33	4.7k 1.4×	4.3k 1.4×	2.8k 1.1×	2.0k 1.0×	1.5k 0.9×	75	9.7k
Xiqun Jiang China	63	4.9k 1.4×	5.4k 1.8×	2.9k 1.1×	3.4k 1.8×	1.7k 1.0×	248	11.8k
Christine Allen Canada	60	6.3k 1.8×	4.3k 1.4×	3.3k 1.3×	1.9k 1.0×	2.4k 1.4×	215	12.6k
Eun Seong Lee South Korea	50	5.8k 1.7×	4.6k 1.5×	3.5k 1.4×	1.5k 0.8×	1.5k 0.9×	217	10.5k
Nazila Kamaly United Kingdom	31	5.0k 1.5×	4.0k 1.3×	3.6k 1.4×	1.5k 0.8×	878 0.5×	62	9.8k
Hamidreza Ghandehari United States	62	6.0k 1.8×	3.7k 1.2×	5.1k 2.0×	2.4k 1.3×	927 0.5×	210	12.8k
Kun Na South Korea	59	4.7k 1.4×	5.2k 1.7×	3.1k 1.2×	2.4k 1.2×	1.0k 0.6×	263	11.5k

Countries citing papers authored by Kristofer J. Thurecht

Since Specialization

Citations

This map shows the geographic impact of Kristofer J. Thurecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristofer J. Thurecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristofer J. Thurecht more than expected).

Fields of papers citing papers by Kristofer J. Thurecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristofer J. Thurecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristofer J. Thurecht. The network helps show where Kristofer J. Thurecht may publish in the future.

Co-authorship network of co-authors of Kristofer J. Thurecht

This figure shows the co-authorship network connecting the top 25 collaborators of Kristofer J. Thurecht. A scholar is included among the top collaborators of Kristofer J. Thurecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristofer J. Thurecht. Kristofer J. Thurecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Howard, Christopher B., Pie Huda, Nicholas L. Fletcher, et al.. (2025). Immune-modulating nanomedicines for enhanced drug delivery to non-small-cell lung cancer. Biomaterials. 317. 123089–123089. 1 indexed citations

Yuen, Daniel, Orlagh M. Feeney, Victoria M. McLeod, et al.. (2025). Nanobody-Mediated Cellular Uptake Maximizes the Potency of Polylysine Dendrimers While Preserving Solid Tumor Penetration. ACS Nano. 19(6). 6044–6057. 3 indexed citations

Fletcher, Nicholas L., et al.. (2025). Development of a Novel Engineered Antibody Format for PSMA-Targeted Radionuclide Therapy. Molecular Pharmaceutics. 22(7). 3666–3678.

Ghosh, Saikat, Zachary H. Houston, Nicholas L. Fletcher, et al.. (2024). A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements. Chemical Science. 15(30). 11748–11760. 5 indexed citations

Sivaram, Amal J., Gary Cowin, Luke McAlary, et al.. (2024). Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy. Journal of Controlled Release. 378. 221–235. 10 indexed citations

Ju, Yi, Shiyao Li, Emily H. Pilkington, et al.. (2024). Patient-Specific Nanoparticle Targeting in Human Leukemia Blood. ACS Nano. 18(42). 29021–29035. 19 indexed citations

Balaji, Arunpandian, Craig A. Bell, Zachary H. Houston, et al.. (2023). Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers. Biomaterials. 302. 122318–122318. 5 indexed citations

Chu, Weijing, Zachary H. Houston, Nicholas L. Fletcher, et al.. (2023). Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic. Biomacromolecules. 24(6). 2674–2690. 4 indexed citations

Lim, Malcolm, Nicholas L. Fletcher, Jodi M. Saunus, et al.. (2023). Targeted Hyperbranched Nanoparticles for Delivery of Doxorubicin in Breast Cancer Brain Metastasis. Molecular Pharmaceutics. 20(12). 6169–6183. 16 indexed citations

10.

Jia, Xinying, Yanni K.‐Y. Chin, Nicholas L. Fletcher, et al.. (2023). Self-cyclisation as a general and efficient platform for peptide and protein macrocyclisation. Communications Chemistry. 6(1). 48–48. 11 indexed citations

11.

Janowicz, Phillip W., Zachary H. Houston, Jens Bunt, et al.. (2022). Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption. Biomaterials. 283. 121416–121416. 22 indexed citations

12.

Simpson, Joshua D., et al.. (2022). Modulating Macrophage Clearance of Nanoparticles: Comparison of Small-Molecule and Biologic Drugs as Pharmacokinetic Modifiers of Soft Nanomaterials. Molecular Pharmaceutics. 19(11). 4080–4097. 7 indexed citations

13.

Fletcher, Nicholas L., Robert Cavanagh, Zachary H. Houston, et al.. (2022). Synthesis, characterisation and evaluation of hyperbranched N-(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines in vitro and in vivo. Biomaterials Science. 10(9). 2328–2344. 5 indexed citations

14.

Simpson, Joshua D., Patricia Monteiro, Stefan Sonderegger, et al.. (2021). Fluorophore Selection and Incorporation Contribute to Permeation and Distribution Behaviors of Hyperbranched Polymers in Multi-Cellular Tumor Spheroids and Xenograft Tumor Models. ACS Applied Bio Materials. 4(3). 2675–2685. 7 indexed citations

15.

Sivaram, Amal J., Andri Wardiana, Sheilajen Alcântara, et al.. (2020). Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting. ACS Nano. 14(10). 13739–13753. 36 indexed citations

16.

Sonderegger, Stefan, Nicholas L. Fletcher, Zachary H. Houston, et al.. (2020). Hyperbranched Poly(2-oxazoline)s and Poly(ethylene glycol): A Structure–Activity Comparison of Biodistribution. Biomacromolecules. 21(8). 3318–3331. 21 indexed citations

17.

Simpson, Joshua D., Adrian V. Fuchs, T.K. Venkatachalam, et al.. (2020). Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery. Chemical Science. 11(12). 3268–3280. 25 indexed citations

18.

Cui, Jiwei, Yi Ju, Matthew Faria, et al.. (2019). Cellular Targeting of Bispecific Antibody-Functionalized Poly(ethylene glycol) Capsules: Do Shape and Size Matter?. ACS Applied Materials & Interfaces. 11(32). 28720–28731. 18 indexed citations

19.

Bain, Amanda L., et al.. (2018). RNA interference to enhance radiation therapy: Targeting the DNA damage response. Cancer Letters. 439. 14–23. 12 indexed citations

20.

Björnmalm, Mattias, Kristofer J. Thurecht, Michael Michael, Andrew M. Scott, & Frank Caruso. (2017). Bridging Bio–Nano Science and Cancer Nanomedicine. ACS Nano. 11(10). 9594–9613. 313 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact